Davies, P., Reuber, M. orcid.org/0000-0002-4104-6705, Grunewald, R. et al. (6 more authors)
(2020)
The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre.
Seizure, 79.
pp. 8-13.
ISSN 1059-1311
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2020 British Epilepsy Association. Published by Elsevier Ltd. This is an author-produced version of a paper subsequently published in Seizure. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 11 May 2020 13:52 |
Last Modified: | 17 Apr 2021 00:38 |
Status: | Published |
Publisher: | Elsevier BV |
Refereed: | Yes |
Identification Number: | 10.1016/j.seizure.2020.03.015 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:160549 |
Download
Filename: Valproate author accepted manuscript.pdf
Licence: CC-BY-NC-ND 4.0